Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,101 to 2,120 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation and roles of RNA modifications in aging-related diseases. | Aging Cell | 2022 | 35718942 | PubTator, text mining | PubMed |
| Hidden codes in mRNA: Control of gene expression by m6A. | Mol Cell | 2022 | 35714585 | PubTator, text mining | PubMed |
| The Role of m6A on Female Reproduction and Fertility: From Gonad Development to Ovarian Aging. | Front Cell Dev Biol | 2022 | 35712673 | PubTator, text mining | PubMed |
| The Interaction Between Epigenetic Changes, EMT, and Exosomes in Predicting Metastasis of Colorectal Cancers (CRC). | Front Oncol | 2022 | 35712512 | PubTator, text mining | PubMed |
| Analysis of Pyroptosis-Related Signature for Predicting Prognosis and Tumor Immune Microenvironment in Pancreatic Cancer. | Front Oncol | 2022 | 35712482 | PubTator, text mining | PubMed |
| Deciphering Obesity-Related Gene Clusters Unearths SOCS3 Immune Infiltrates and 5mC/m6A Modifiers in Ossification of Ligamentum Flavum Pathogenesis. | Front Endocrinol (Lausanne) | 2022 | 35712246 | PubTator, text mining | PubMed |
| The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma. | Front Immunol | 2022 | 35711459 | PubTator, text mining | PubMed |
| Effects of N6-Methyladenosine Modification on Cancer Progression: Molecular Mechanisms and Cancer Therapy. | Front Oncol | 2022 | 35707365 | PubTator, text mining | PubMed |
| The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms. | J Exp Clin Cancer Res | 2022 | 35701841 | PubTator, text mining | PubMed |
| Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival. | BMC Biol | 2022 | 35698136 | PubTator, text mining | PubMed |
| Epigenetics Regulates Antitumor Immunity in Melanoma. | Front Immunol | 2022 | 35693795 | PubTator, text mining | PubMed |
| METTL3-Mediated N6-Methyladenosine Modification of Trim59 mRNA Protects Against Sepsis-Induced Acute Respiratory Distress Syndrome. | Front Immunol | 2022 | 35693774 | PubTator, text mining | PubMed |
| Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis. | J Thorac Dis | 2022 | 35693610 | PubTator, text mining | PubMed |
| The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC. | Front Genet | 2022 | 35692828 | PubTator, text mining | PubMed |
| An m6A/m5C/m1A/m7G-Related Long Non-coding RNA Signature to Predict Prognosis and Immune Features of Glioma. | Front Genet | 2022 | 35692827 | PubTator, text mining | PubMed |
| Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration. | J Immunol Res | 2022 | 35692505 | PubTator, text mining | PubMed |
| Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications. | Front Endocrinol (Lausanne) | 2022 | 35692393 | PubTator, text mining | PubMed |
| RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m6 A-IGF2BP2-dependent manner. | J Clin Lab Anal | 2022 | 35689537 | PubTator, text mining | PubMed |
| Interaction between m6A methylation and noncoding RNA in glioma. | Cell Death Discov | 2022 | 35688823 | PubTator, text mining | PubMed |
| Targeting m6A modification inhibits herpes virus 1 infection. | Genes Dis | 2022 | 35685469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=106